Prozac and Lexapro are both SSRIs — selective serotonin reuptake inhibitors — and both treat depression and anxiety effectively. But "both are SSRIs" can obscure real and clinically meaningful differences in how they behave inside the body.
Here is a practical comparison of the two medications from a clinical standpoint.
What Is Prozac (Fluoxetine)?
Fluoxetine was approved by the FDA in 1987 and was the first SSRI to reach widespread clinical use. The brand name Prozac became nearly synonymous with antidepressant treatment in the 1990s. Today, generic fluoxetine is one of the least expensive antidepressants available.
Prozac works like all SSRIs — by blocking the serotonin transporter (SERT) and increasing serotonin availability in the synapse. What makes it pharmacologically distinctive is its extremely long half-life. Fluoxetine itself has a half-life of 1–4 days, and its active metabolite norfluoxetine has a half-life of 5–15 days. This means the drug remains active in the body for weeks after the last dose.
FDA approvals for fluoxetine include: major depressive disorder (including in children aged 8 and older), generalized anxiety disorder, obsessive-compulsive disorder, bulimia nervosa, panic disorder, and bipolar depression in combination with olanzapine (as Symbyax).
What Is Lexapro (Escitalopram)?
Lexapro is the brand name for escitalopram, approved by the FDA in 2002. Escitalopram is the S-enantiomer of citalopram (Celexa) — essentially the pharmacologically active half of the citalopram molecule, isolated and formulated separately. This gives it a somewhat cleaner receptor selectivity profile than the parent compound.
Escitalopram is FDA-approved for major depressive disorder (in adults and adolescents aged 12 and older) and generalized anxiety disorder in adults. It has a half-life of approximately 27–32 hours, which is typical for the SSRI class.
Lexapro is consistently ranked among the best-tolerated SSRIs in large network meta-analyses, and escitalopram and sertraline frequently appear together at the top of comparative efficacy and acceptability rankings.
Key Differences Between Prozac and Lexapro
| | Prozac (fluoxetine) | Lexapro (escitalopram) |
|---|---|---|
| Half-life | 1–4 days (+ norfluoxetine 5–15 days) | ~27–32 hours |
| Missed doses | Very forgiving — the long half-life acts as a natural buffer | Less forgiving; missed doses may cause more noticeable effects |
| Discontinuation syndrome | Rarely significant — the drug self-tapers | Possible with abrupt discontinuation; taper recommended |
| Drug interactions | Significant — potent CYP2D6 and CYP2C19 inhibitor | Mild — far fewer clinically significant interactions |
| Activation | More activating; can cause insomnia in sensitive patients | Mildly sedating or neutral |
| Ages approved | Children 8+ (depression), all ages (OCD) | Adolescents 12+ (depression only) |
| Elderly patients | Used, but interaction burden requires care | Often preferred in elderly — cleaner profile |
| Cost (generic) | Very inexpensive | Inexpensive; slightly higher than fluoxetine in some plans |
Side Effects: What to Expect
Both medications share the core SSRI side effect profile — nausea (usually in the first 1–2 weeks), headache, insomnia or sedation, and sexual dysfunction (delayed orgasm, reduced libido). These side effects are not unique to either drug but vary somewhat between them.
Fluoxetine's distinctive side effect considerations:
- More activating than most SSRIs — some patients appreciate the energy; others find it causes insomnia or agitation
- Longer to reach steady state (takes 4–5 weeks, versus 1–2 weeks for escitalopram)
- Fewer complaints about emotional blunting at standard doses in some clinical observations
- Because it persists in the system for weeks, side effects from a dose change also persist longer
Escitalopram's distinctive side effect considerations:
- Better overall tolerability scores in several large comparative trials
- Mild sedating effect for some patients, which can be a benefit if insomnia is not the problem
- QT prolongation was identified as a concern with citalopram at higher doses — escitalopram does not carry the same warning at therapeutic doses, but cardiac monitoring is still reasonable for patients at risk
- Discontinuation symptoms (dizziness, "brain zaps," flu-like feelings) are possible if stopped abruptly, though generally milder than with paroxetine or venlafaxine
Who Gets Prozac?
Fluoxetine tends to be chosen when:
- Discontinuation is a known concern. For patients who have previously struggled with stopping an SSRI — or whose lifestyle makes consistent daily dosing difficult — the extremely long half-life of fluoxetine provides a built-in buffer. Missing several days of fluoxetine has far less impact than missing several days of escitalopram.
- OCD is present. Fluoxetine is approved and well-studied for OCD. Escitalopram does not have an FDA indication for OCD (though it is sometimes used off-label).
- Bulimia nervosa is a co-occurring condition. Fluoxetine is the only antidepressant FDA-approved for bulimia.
- Pediatric depression. Fluoxetine is FDA-approved for depression in children as young as 8, making it the first-line pharmacotherapy option in that age group.
- Cost is the primary concern. Generic fluoxetine is among the least expensive antidepressants available at any pharmacy.
Fluoxetine requires more attention to drug interactions than escitalopram, particularly in patients on tamoxifen (it can reduce tamoxifen's efficacy), tricyclic antidepressants, certain antipsychotics, or pain medications metabolized through CYP2D6.
Who Gets Lexapro?
Escitalopram tends to be chosen when:
- Simplicity and tolerability are the priority. Lexapro consistently ranks among the best-tolerated SSRIs in large head-to-head trials and is frequently recommended as a clean first-line choice.
- The patient is on multiple other medications. Escitalopram's low drug interaction burden makes it easier to use alongside complex medication regimens — particularly in older adults managing multiple conditions.
- Anxiety is the predominant symptom. Escitalopram is well-studied for GAD and is often the first SSRI chosen when anxiety rather than depression is the primary complaint.
- The patient is older. Escitalopram is commonly preferred in elderly patients because of its cleaner interaction profile and the absence of the dose-dependent QT concern associated with its parent compound citalopram.
Switching Between Them
Switching from Prozac to Lexapro or vice versa is generally straightforward for a psychiatrist, though Prozac's long half-life means there is often a washout period of 1–2 weeks before starting another medication — particularly relevant if the next medication is an MAOI, but also worth noting for any switch.
A failed trial of one SSRI does not reliably predict failure with another. Patients who did not respond to fluoxetine may still respond to escitalopram, and vice versa. Non-response to multiple SSRIs is a signal that a different mechanism (SNRI, bupropion, mirtazapine, or augmentation) may be worth exploring.
When to Talk to a Psychiatrist
The SSRI comparison questions that feel most important — "Which one is better for me?" — are usually questions about your specific clinical picture, not the medications in the abstract. Your other medications, your history of what has and hasn't worked, whether anxiety or depression is more dominant, and your lifestyle all shape the answer more than a general comparison does.
An anxiety evaluation or depression evaluation at SLS Psychiatry is designed to work through exactly that picture and arrive at a specific medication plan, not a generic recommendation.